Belén Garijo, the new CEO of French pharmaceutical giant Sanofi, has revealed her plan to accelerate the company's growth. Having been in the role for three months, Garijo has already increased Sanofi’s ambitions for 2030. Her strategy centers on three key pillars: discipline, innovation, and strategic acquisitions. This approach signals a focused effort to enhance efficiency and productivity within the organization. The emphasis on innovation suggests a commitment to developing new treatments and technologies. Increased ambition indicates a proactive approach to expanding Sanofi's market position and overall financial performance.